These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 12423010

  • 21. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
    Fraser AD, Howell P.
    J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
    [Abstract] [Full Text] [Related]

  • 22. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT, Taylor BG.
    Forensic Sci Int; 2006 Mar 10; 157(2-3):106-16. PubMed ID: 15899564
    [Abstract] [Full Text] [Related]

  • 23. [Detection of lysergic acid diethylamide in human urine: elimination, screening and analytical confirmation].
    Vu-Duc T, Vernay A, Calanca A.
    Schweiz Med Wochenschr; 1991 Dec 14; 121(50):1887-90. PubMed ID: 1759150
    [Abstract] [Full Text] [Related]

  • 24. LC-MS analysis of 2-oxo-3-hydroxy LSD from urine using a Speedisk positive-pressure processor with Cerex PolyChrom CLIN II columns.
    Horn CK, Klette KL, Stout PR.
    J Anal Toxicol; 2003 Oct 14; 27(7):459-63. PubMed ID: 14607000
    [Abstract] [Full Text] [Related]

  • 25. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA, Schwarzhoff RH, Hubster EC, Liserio MK.
    Clin Chem; 1993 Oct 14; 39(10):2137-46. PubMed ID: 8403399
    [Abstract] [Full Text] [Related]

  • 26. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y, Ojanperä I, Rasanen I, Vuori E.
    Forensic Sci Int; 2003 Jan 28; 131(2-3):148-55. PubMed ID: 12590054
    [Abstract] [Full Text] [Related]

  • 27. The analysis of lysergide (LSD): the development of novel enzyme immunoassay and immunoaffinity extraction procedures together with an HPLC-MS confirmation procedure.
    Webb KS, Baker PB, Cassells NP, Francis JM, Johnston DE, Lancaster SL, Minty PS, Reed GD, White SA.
    J Forensic Sci; 1996 Nov 28; 41(6):938-46. PubMed ID: 8914284
    [Abstract] [Full Text] [Related]

  • 28. LC-mS analysis of human urine specimens for 2-oxo-3-hydroxy LSD: method validation for potential interferants and stability study of 2-oxo-3-hydroxy LSD under various storage conditions.
    Klette KL, Horn CK, Stout PR, Anderson CJ.
    J Anal Toxicol; 2002 Nov 28; 26(4):193-200. PubMed ID: 12054358
    [Abstract] [Full Text] [Related]

  • 29. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
    Sklerov JH, Magluilo J, Shannon KK, Smith ML.
    J Anal Toxicol; 2000 Oct 28; 24(7):543-9. PubMed ID: 11043657
    [Abstract] [Full Text] [Related]

  • 30. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
    de Kanel J, Vickery WE, Waldner B, Monahan RM, Diamond FX.
    J Forensic Sci; 1998 May 28; 43(3):622-5. PubMed ID: 9608700
    [Abstract] [Full Text] [Related]

  • 31. 2-oxo-3-hydroxy-LSD: an important LSD metabolite?
    Verstraete AG, Van de Velde EJ.
    Acta Clin Belg; 1999 May 28; 53 Suppl 1():94-6. PubMed ID: 10216992
    [Abstract] [Full Text] [Related]

  • 32. Stability study of LSD under various storage conditions.
    Li Z, McNally AJ, Wang H, Salamone SJ.
    J Anal Toxicol; 1998 Oct 28; 22(6):520-5. PubMed ID: 9788528
    [Abstract] [Full Text] [Related]

  • 33. CEDIA for screening drugs of abuse in urine and the effect of adulterants.
    Wu AH, Forte E, Casella G, Sun K, Hemphill G, Foery R, Schanzenbach H.
    J Forensic Sci; 1995 Jul 28; 40(4):614-8. PubMed ID: 7595298
    [Abstract] [Full Text] [Related]

  • 34. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse.
    Beck O, Rausberg L, Al-Saffar Y, Villen T, Karlsson L, Hansson T, Helander A.
    Drug Test Anal; 2014 May 28; 6(5):492-9. PubMed ID: 24665024
    [Abstract] [Full Text] [Related]

  • 35. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
    Darragh A, Snyder ML, Ptolemy AS, Melanson S.
    Pain Physician; 2014 May 28; 17(4):359-66. PubMed ID: 25054395
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of a commercial radioimmunoassay kit for the detection of lysergide (LSD) in serum, whole blood, urine and stomach contents.
    Altunkaya D, Smith RN.
    Forensic Sci Int; 1990 Sep 28; 47(2):113-21. PubMed ID: 2227729
    [Abstract] [Full Text] [Related]

  • 37. Determination of LSD in urine with high-performance liquid chromatography--mass spectrometry.
    Bodin K, Svensson JO.
    Ther Drug Monit; 2001 Aug 28; 23(4):389-93. PubMed ID: 11477321
    [Abstract] [Full Text] [Related]

  • 38. An evaluation of the OnTrak Testcup-er on-site urine drug-testing device for drugs commonly encountered from emergency departments.
    Peace MR, Poklis JL, Tarnai LD, Poklis A.
    J Anal Toxicol; 2002 Oct 28; 26(7):500-3. PubMed ID: 12423007
    [Abstract] [Full Text] [Related]

  • 39. Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography-positive ion chemical ionization-mass spectrometry.
    Moody DE, Spanbauer AC, Taccogno JL, Smith EK.
    J Anal Toxicol; 2004 Mar 28; 28(2):86-93. PubMed ID: 15068561
    [Abstract] [Full Text] [Related]

  • 40. Gas chromatographic/mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples.
    Musshoff F, Daldrup T.
    Forensic Sci Int; 1997 Aug 04; 88(2):133-40. PubMed ID: 9251232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.